57 related articles for article (PubMed ID: 25863179)
21. Generation and evaluation of reassortant influenza vaccines made by reverse genetics for H9N2 avian influenza in Korea.
Song JM; Lee YJ; Jeong OM; Kang HM; Kim HR; Kwon JH; Kim JH; Seong BL; Kim YJ
Vet Microbiol; 2008 Aug; 130(3-4):268-76. PubMed ID: 18374520
[TBL] [Abstract][Full Text] [Related]
22. Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: a transcriptomics analysis of adjuvanted vaccines.
Reemers SS; Jansen C; Koerkamp MJ; van Haarlem D; van de Haar P; Degen WG; van Eden W; Vervelde L
Vaccine; 2010 Aug; 28(38):6351-60. PubMed ID: 20637308
[TBL] [Abstract][Full Text] [Related]
23. Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice.
Pushko P; Tumpey TM; Bu F; Knell J; Robinson R; Smith G
Vaccine; 2005 Dec; 23(50):5751-9. PubMed ID: 16143432
[TBL] [Abstract][Full Text] [Related]
24. Enhanced immune response of BMDCs pulsed with H9N2 AIV and CpG.
Lin J; Yin YY; Qin T; Zhu LQ; Yu QH; Yang Q
Vaccine; 2014 Nov; 32(50):6783-90. PubMed ID: 25454862
[TBL] [Abstract][Full Text] [Related]
25. Differences in transmissibility and pathogenicity of reassortants between H9N2 and 2009 pandemic H1N1 influenza A viruses from humans and swine.
He L; Wu Q; Jiang K; Duan Z; Liu J; Xu H; Cui Z; Gu M; Wang X; Liu X; Liu X
Arch Virol; 2014 Jul; 159(7):1743-54. PubMed ID: 24510170
[TBL] [Abstract][Full Text] [Related]
26. A nonpathogenic duck-origin H9N2 influenza A virus adapts to high pathogenicity in mice.
Liu Q; Chen H; Huang J; Chen Y; Gu M; Wang X; Hu S; Liu X; Liu X
Arch Virol; 2014 Sep; 159(9):2243-52. PubMed ID: 24696271
[TBL] [Abstract][Full Text] [Related]
27. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus.
Yamada K; Ogawa H; Hara A; Yoshida Y; Yonezawa Y; Karibe K; Nghia VB; Yoshimura H; Yamamoto Y; Yamada M; Nakamura K; Imai K
Antiviral Res; 2009 Jul; 83(1):35-44. PubMed ID: 19501255
[TBL] [Abstract][Full Text] [Related]
28. Comparison of biological characteristics of H9N2 avian influenza viruses isolated from different hosts.
Zhu Y; Yang Y; Liu W; Liu X; Yang D; Sun Z; Ju Y; Chen S; Peng D; Liu X
Arch Virol; 2015 Apr; 160(4):917-27. PubMed ID: 25616845
[TBL] [Abstract][Full Text] [Related]
29. Domestic cats and dogs are susceptible to H9N2 avian influenza virus.
Zhang K; Zhang Z; Yu Z; Li L; Cheng K; Wang T; Huang G; Yang S; Zhao Y; Feng N; Fu J; Qin C; Gao Y; Xia X
Virus Res; 2013 Jul; 175(1):52-7. PubMed ID: 23603563
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of transmission route and replication efficiency of H9N2 avian influenza virus.
Shi H; Ashraf S; Gao S; Lu J; Liu X
Avian Dis; 2010 Mar; 54(1):22-7. PubMed ID: 20408394
[TBL] [Abstract][Full Text] [Related]
31. Human influenza virus infection and apoptosis induction in human vascular endothelial cells.
Sumikoshi M; Hashimoto K; Kawasaki Y; Sakuma H; Suzutani T; Suzuki H; Hosoya M
J Med Virol; 2008 Jun; 80(6):1072-8. PubMed ID: 18428129
[TBL] [Abstract][Full Text] [Related]
32. Full-genome analysis of avian influenza virus H9N2 from Bangladesh reveals internal gene reassortments with two distinct highly pathogenic avian influenza viruses.
Parvin R; Heenemann K; Halami MY; Chowdhury EH; Islam MR; Vahlenkamp TW
Arch Virol; 2014 Jul; 159(7):1651-61. PubMed ID: 24420161
[TBL] [Abstract][Full Text] [Related]
33. Immunity to influenza A H9N2 viruses induced by infection and vaccination.
Lu X; Renshaw M; Tumpey TM; Kelly GD; Hu-Primmer J; Katz JM
J Virol; 2001 May; 75(10):4896-901. PubMed ID: 11312361
[TBL] [Abstract][Full Text] [Related]
34. [Construction and characterization of reverse genetic system for H9N2 avian influenza].
Liu LQ; Dong J; Bo H; Wen LY; Xin L; Zhang Y; Li Z; Dong LB; Wang M; Guo YJ; Shu YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):41-3. PubMed ID: 19799015
[TBL] [Abstract][Full Text] [Related]
35. Microarray analyses of differentially expressed human genes and biological processes in ECV304 cells infected with rubella virus.
Mo XY; Ma W; Zhang Y; Zhao H; Deng Y; Yuan W; Wang Y; Li Y; Zhu C; Liu M; Wu X
J Med Virol; 2007 Nov; 79(11):1783-91. PubMed ID: 17854033
[TBL] [Abstract][Full Text] [Related]
36. A strain of influenza A H9N2 virus repeatedly isolated from human population in China.
Gou Y; Xie J; Wang M
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Sep; 14(3):209-12. PubMed ID: 11498680
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a pathogenic H9N2 influenza A virus isolated from central China in 2007.
Wu R; Sui ZW; Zhang HB; Chen QJ; Liang WW; Yang KL; Xiong ZL; Liu ZW; Chen Z; Xu DP
Arch Virol; 2008; 153(8):1549-55. PubMed ID: 18574551
[TBL] [Abstract][Full Text] [Related]
38. An Ultrasensitive Mechanism Regulates Influenza Virus-Induced Inflammation.
Shoemaker JE; Fukuyama S; Eisfeld AJ; Zhao D; Kawakami E; Sakabe S; Maemura T; Gorai T; Katsura H; Muramoto Y; Watanabe S; Watanabe T; Fuji K; Matsuoka Y; Kitano H; Kawaoka Y
PLoS Pathog; 2015 Jun; 11(6):e1004856. PubMed ID: 26046528
[TBL] [Abstract][Full Text] [Related]
39. Comprehensive Transcriptomic Analysis Identifies Novel Antiviral Factors Against Influenza A Virus Infection.
Zhou A; Dong X; Liu M; Tang B
Front Immunol; 2021; 12():632798. PubMed ID: 34367124
[TBL] [Abstract][Full Text] [Related]
40. Immune Mechanisms in Cardiovascular Diseases Associated With Viral Infection.
Gopal R; Marinelli MA; Alcorn JF
Front Immunol; 2020; 11():570681. PubMed ID: 33193350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
